Sunbelt Securities’s Caribou Biosciences CRBU Stock Holding History

Sunbelt Securities’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18	Closed	-$29	–	2981
2025 Q4	$29	Sell	18 -117	-87%	-$246	﹤0.01%	2699
2025 Q3	$315	Buy	+135	New	+$255	﹤0.01%	2338

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sunbelt Securities's CRBU Position: Q1 2026 in Review

Sunbelt Securities sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 18 shares — an estimated $29 sold.

Sunbelt Securities first reported a position in CRBU in Q3 2025 and held it in 2 quarters. The position peaked at $315 in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Sunbelt Securities reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
Sunbelt Securities sold 18 Caribou Biosciences shares in Q1 2026, an estimated $29.
Sunbelt Securities first reported a position in Caribou Biosciences in Q3 2025 and held it in 2 quarters.
Sunbelt Securities's Caribou Biosciences position peaked at $315 in Q3 2025.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.